Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating intensified conditioning with high-dose etoposide for adults undergoing allogeneic hematopoietic stem cell transplantation for acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etoposide (Etoposide)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Lymphoblastic Leukemia, Stem Cell Transplantation, Hematopoietic | Phase 2, Phase 3 | Status: COMPLETED